James Hippel - Nov 1, 2024 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
CFO
Signature
/s/ Andrew Nick as Attorney-in-Fact for James Hippel pursuant to Power of Attorney previously filed
Stock symbol
TECH
Transactions as of
Nov 1, 2024
Transactions value $
-$487,632
Form type
4
Date filed
11/5/2024, 04:46 PM
Previous filing
Aug 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $0 +13.2K +13.17% $0.00 113K Nov 1, 2024 Direct
transaction TECH Common Stock Tax liability -$488K -6.48K -5.73% $75.31 107K Nov 1, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Restricted Stock Units Options Exercise $0 -13.2K -50% $0.00 13.2K Nov 1, 2024 Common Stock 13.2K Direct F3, F8
transaction TECH Restricted Stock Units Award $0 +34.6K $0.00 34.6K Nov 1, 2024 Common Stock 34.6K Direct F3, F12
holding TECH Stock Options (Right to Buy) 53.9K Nov 1, 2024 Common Stock 53.9K $31.26 Direct F1
holding TECH Stock Options (Right to Buy) 169K Nov 1, 2024 Common Stock 169K $44.33 Direct F1
holding TECH Stock Options (Right to Buy) 186K Nov 1, 2024 Common Stock 186K $47.60 Direct F1
holding TECH Stock Options (Right to Buy) 167K Nov 1, 2024 Common Stock 167K $66.97 Direct F1
holding TECH Stock Options (Right to Buy) 40.5K Nov 1, 2024 Common Stock 40.5K $120.46 Direct F2
holding TECH Performance Restricted Stock Units 10.9K Nov 1, 2024 Common Stock 10.9K Direct F3, F4
holding TECH Performance Stock Options (Right to Buy) 33.9K Nov 1, 2024 Common Stock 33.9K $94.52 Direct F4
holding TECH Stock Options (Right to Buy) 45.2K Nov 1, 2024 Common Stock 45.2K $94.52 Direct F5
holding TECH Performance Restricted Stock Units 13.9K Nov 1, 2024 Common Stock 13.9K Direct F3, F6
holding TECH Performance Stock Options (Right to Buy) 37.3K Nov 1, 2024 Common Stock 37.3K $84.61 Direct F6
holding TECH Stock Options (Right to Buy) 45.9K Nov 1, 2024 Common Stock 45.9K $84.61 Direct F7
holding TECH Performance Restricted Stock Units 24.1K Nov 1, 2024 Common Stock 24.1K Direct F3, F9
holding TECH Restricted Stock Units 12K Nov 1, 2024 Common Stock 12K Direct F3, F10
holding TECH Stock Options (Right to Buy) 32.4K Nov 1, 2024 Common Stock 32.4K $74.91 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully exercisable.
F2 Options to purchase 10,134 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
F4 Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F5 Options to purchase 11,305 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
F6 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7 Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026.
F8 On 11/1/2024, the Board of Directors certified vesting of ____ performance RSUs. The remaining 13,159 restricted stock units vest on 11/1/2025.
F9 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F10 4,010 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 4,011 restricted stock units vest on 8/15/2027.
F11 Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028.
F12 11,545 restricted stock units vest on each of 11/1/2025 and 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027.